I was told there are no more treatment options. What can I still check?
Ask three things before accepting that conclusion: whether the tumor has been fully profiled, including recent re-testing; whether a documented search of clinical trials, including early-phase and out-of-area sites, has been done; and whether expanded access or a second opinion at a high-volume center has been considered. Sometimes the answer is still no, but you deserve to know it was checked.
What "no options" can mean
Often it means no standard options remain at that center. That is an honest and important statement. It is different from saying no trial anywhere could fit, or that the tumor's biology has been fully explored.
- Comprehensive genomic profiling, ideally recent, including RNA fusions
- Phase 1 and basket trials that enroll by mutation rather than cancer type
- Trial sites outside your region, and what travel they would really require
- FDA expanded access for drugs still in trials
- Palliative and supportive care, which can run alongside any of these
Keeping it realistic
Early-phase trials have strict eligibility and uncertain benefit. A careful review explains what is realistically reachable, given your health, records, and location, so families can make decisions with clear eyes rather than false hope.
Related questions
Can you enroll me in a trial?
No one outside the trial team can guarantee enrollment. A review identifies candidates, checks eligibility against your records, and prepares the information your oncologist and the trial site need.
Reviewed 2026-10-11 by Kim Lockheimer, PhD, DFM.